214 related articles for article (PubMed ID: 30021463)
1. Efficacy and Safety of a Biosimilar Versus Branded Enoxaparin in the Prevention of Venous Thromboembolism Following Major Abdominal Surgery: A Randomized, Prospective, Single-Blinded, Multicenter Clinical Trial.
Ramacciotti E; Ferreira U; Costa AJV; Raymundo SRO; Correa JA; Neto SG; Osvaldt AB; Agati L; Aguiar VCR; Davila R; Caltabiano TB; Magella FM; Volpiani GG; Castelli V; Caffaro RA; DalAcqua LZ; Matheus WE; Sato DY; Russeff GJDS; de Souza DG; Pazetto LE; de Lima TAM; Colnago EMDS; Fugii EY; Mussalem JS; Assao VT; Toffoletto O; Rodrigues DG; Afiune JB; Araujo GR
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1208-1215. PubMed ID: 30021463
[TBL] [Abstract][Full Text] [Related]
2. Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial.
Kakkar AK; Agnelli G; Fisher W; George D; Lassen MR; Mismetti P; Mouret P; Murphy J; Lawson F; Turpie AG;
Ann Surg; 2014 Jun; 259(6):1073-9. PubMed ID: 24374549
[TBL] [Abstract][Full Text] [Related]
3. Biosimilar versus branded enoxaparin to prevent postoperative venous thromboembolism after surgery for digestive tract cancer: Randomized trial.
Dziri C; Ben Hmida W; Dougaz W; Khalfallah M; Samaali I; Jerraya H; Bouasker I; Nouira R
PLoS One; 2023; 18(11):e0293269. PubMed ID: 37910523
[TBL] [Abstract][Full Text] [Related]
4. Generic versus branded enoxaparin in the prevention of venous thromboembolism following major abdominal surgery: report of an exploratory clinical trial.
Gomes M; Ramacciotti E; Henriques AC; Araujo GR; Szultan LA; Miranda F; Thethi I
Clin Appl Thromb Hemost; 2011; 17(6):633-9. PubMed ID: 21949036
[TBL] [Abstract][Full Text] [Related]
5. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
[TBL] [Abstract][Full Text] [Related]
6. Safety and effectiveness of biosimilar enoxaparin (Inhixa) for the prevention of thromboembolism in medical and surgical inpatients.
Fantoni C; Bertù L; Faioni EM; Froiio C; Mariani N; Ageno W
Intern Emerg Med; 2021 Jun; 16(4):933-939. PubMed ID: 33108640
[TBL] [Abstract][Full Text] [Related]
7. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
8. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
9. Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?
Marques de Marino P; Rial Horcajo R; Garcia Grandal T; Sanchez Hervas L; Serrano Hernando FJ; Herraiz Martinez MA; Coronado Martin PJ
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():90-95. PubMed ID: 30245443
[TBL] [Abstract][Full Text] [Related]
10. Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3).
Eriksson BI; Agnelli G; Gallus AS; Lassen MR; Prins MH; Renfurm RW; Kashiwa M; Turpie AG
Thromb Haemost; 2014 Feb; 111(2):213-25. PubMed ID: 24136153
[TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis with dabigatran after total hip arthroplasty in Indian patients: A subanalysis of a double-blind, double-dummy, randomized RE-NOVATE II study.
Malhotra R; Babhulkar S; Sanjib KB; Clemens A; Dadi A; Iyer R; Kamath S; Mody B; Mutha S; Reddy G; Shah V; Shah V; Shetty N; Tapasvi S; Wadhwa M
Asian J Surg; 2017 Apr; 40(2):145-151. PubMed ID: 27143213
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
[TBL] [Abstract][Full Text] [Related]
13. Generic versus branded enoxaparin in prophylaxis and treatment of vein thrombosis.
Casella IB; Puech-Leão P
Rev Assoc Med Bras (1992); 2015; 61(1):44-50. PubMed ID: 25909208
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
16. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
Alalaf SK; Jawad RK; Muhammad PR; Ali MS; Al Tawil NG
BMC Pregnancy Childbirth; 2015 Mar; 15():72. PubMed ID: 25884460
[TBL] [Abstract][Full Text] [Related]
17. Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2).
Eriksson BI; Turpie AG; Lassen MR; Prins MH; Agnelli G; Kälebo P; Wetherill G; Wilpshaar JW; Meems L;
J Thromb Haemost; 2010 Apr; 8(4):714-21. PubMed ID: 20088935
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of short-term (3 days) enoxaparin in preventing venous thromboembolism after gastric cancer surgery: A single-center, prospective cohort study.
Kuroda S; Kikuchi S; Kakiuchi Y; Watanabe M; Kuwada K; Tsumura T; Nishizaki M; Kagawa S; Hinotsu S; Fujiwara T
Int J Surg; 2021 May; 89():105946. PubMed ID: 33892160
[TBL] [Abstract][Full Text] [Related]
19. A Phase II Clinical Trial of the Efficacy and Safety of Short-term (3 days) Enoxaparin for the Prevention of Venous Thromboembolism after Gastric Cancer Surgery.
Kuroda S; Kikuchi S; Nishizaki M; Kagawa S; Hinotsu S; Fujiwara T
Acta Med Okayama; 2016 Oct; 70(5):401-404. PubMed ID: 27777435
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.
Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA
Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
